Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL-Reference-Cited by-同舟云学术

Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL

Published:2021-01-06 Issue:5 Volume:478 Page:893-904
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Terasaki Mika^ORCID,Terasaki Yasuhiro,Wakamatsu Kyoko,Kuwahara Naomi,Yoneyama Koichi,Kawase Rieko,Kurose Keisuke,Toda Etsuko,Endo Yoko,Kunugi Shinobu,Kajimoto Yusuke,Shimizu Akira

Funder

the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-020-02996-1.pdf

Reference44 articles.

1. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF (1993) Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71:1702–1709. https://doi.org/10.1002/cncr.2820710440

2. Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54:355–364. https://doi.org/10.1111/j.1365-2559.2009.03231.x

3. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E (2012) Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. Maturitas 72:56–60. https://doi.org/10.1016/j.maturitas.2012.01.021

4. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR III, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2018) Uterine Neoplasms, Version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 16:170–199. https://doi.org/10.6004/jnccn.2018.0006

5. Wu TI, Chang TC, Hsueh S, Hsu KH, Chou HH, Huang HJ, Lai CH (2006) Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol 100:166–172. https://doi.org/10.1016/j.ygyno.2005.08.010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine Leiomyosarcoma With Osteoclast-like Giant Cells: Report of 2 Cases and Review of Literature;International Journal of Gynecological Pathology;2023-06-15

2. Clinically Aggressive Uterine Epithelioid Leiomyosarcoma with Rhabdomyoblastic Differentiation and High Proliferation Rate: A Case Report;American Journal of Case Reports;2023-04-11

3. Case Report: A Case of Gallbladder Carcinosarcoma With Osteoclast-like Multinucleated Giant Cells that Was Associated With RANK‐RANKL Signaling;Pathology and Oncology Research;2022-03-23